Buccal Drug Delivery Systems Market Revenue Forecasts To 2028
Buccal Drug Delivery Systems Industry Overview The global buccal drug delivery systems market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant growth potential due to constant research and development in this field. Compared to oral dosage form, buccal delivery is considered the most convenient and preferred choice, especially among geriatric patients. This drug delivery route ensures elimination of first pass metabolism, allowing drugs that are pH sensitive and easily degraded to be administered effectively. Quicker absorption, minimized biofluid interaction, reduced side effects, high concentration availability at the target site, and shorter treatment regime are some of the factors responsible for the increased adoption of buccal drug delivery, thus driving the preference for these formulations. Gather more insights about the market drivers, ...